Evaluating triple therapy with lenvatinib, PD-1 inhibitor and transarterial chemoembolization for unresectable intrahepatic cholangiocarcinoma: A retrospective study. The efficacy and safety of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results